Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1970 1
1971 2
1972 1
1974 2
1975 1
1983 1
1984 2
1986 3
1987 3
1988 1
1989 3
1990 1
1991 3
1992 1
1993 4
1994 1
1995 2
1996 1
1998 2
1999 1
2000 2
2001 3
2002 2
2003 3
2004 1
2006 2
2007 2
2008 3
2009 2
2010 4
2011 4
2012 7
2013 6
2014 13
2015 20
2016 21
2017 27
2018 21
2019 17
2020 16
2021 20
2022 15
2023 24
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA, Ji L, Xu X, Devidas M, Hogan LE, Borowitz MJ, Raetz EA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Pulsipher MA, Hunger SP, Loh ML. Brown PA, et al. Among authors: bernhardt mb. JAMA. 2021 Mar 2;325(9):833-842. doi: 10.1001/jama.2021.0669. JAMA. 2021. PMID: 33651090 Free PMC article. Clinical Trial.
Organotherapy.
Bernhardt MS. Bernhardt MS. JAMA Dermatol. 2013 Dec;149(12):1366. doi: 10.1001/jamadermatol.2013.5877. JAMA Dermatol. 2013. PMID: 24352719 No abstract available.
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
Hogan LE, Brown PA, Ji L, Xu X, Devidas M, Bhatla T, Borowitz MJ, Raetz EA, Carroll A, Heerema NA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Hunger SP, Loh ML. Hogan LE, et al. Among authors: bernhardt mb. J Clin Oncol. 2023 Sep 1;41(25):4118-4129. doi: 10.1200/JCO.22.02200. Epub 2023 May 31. J Clin Oncol. 2023. PMID: 37257143 Clinical Trial.
ERASER.
Fiehler J, Thomalla G, Bernhardt M, Kniep H, Berlis A, Dorn F, Eckert B, Kemmling A, Langner S, Remonda L, Reith W, Rohde S, Möhlenbruch M, Bendszus M, Forkert ND, Gellissen S. Fiehler J, et al. Among authors: bernhardt m. Stroke. 2019 May;50(5):1275-1278. doi: 10.1161/STROKEAHA.119.024858. Stroke. 2019. PMID: 31009356 Clinical Trial.
Perleche.
Bernhardt M. Bernhardt M. Skinmed. 2022 Oct 31;20(5):362. eCollection 2022. Skinmed. 2022. PMID: 36314702 No abstract available.
Recent Advances in Melanoma Tumorigenesis.
Bernhardt M, Bernhardt A. Bernhardt M, et al. J Drugs Dermatol. 2022 Dec 1;21(12):1289-1293. doi: 10.36849/JDD.6814. J Drugs Dermatol. 2022. PMID: 36468958 Review.
New Paradigms in Orthopedic Education.
Bogener JW, Bernhardt M, Cil A. Bogener JW, et al. Among authors: bernhardt m. Orthopedics. 2016 Sep 1;39(5):269-71. doi: 10.3928/01477447-20160823-02. Orthopedics. 2016. PMID: 27636682 No abstract available.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
[Peripheral neuroblastic tumors in childhood].
Bernhardt M, Vokuhl C. Bernhardt M, et al. Pathologie (Heidelb). 2023 Nov;44(6):366-372. doi: 10.1007/s00292-023-01227-z. Epub 2023 Oct 11. Pathologie (Heidelb). 2023. PMID: 37819531 Review. German.
254 results